Literature DB >> 26136860

Association between preeclampsia and the CXC chemokine family (Review).

Xijing Liu1, L I Dai1, Rong Zhou1.   

Abstract

Preeclampsia is a major cause of maternal and perinatal mortality and morbidity, characterized by gestational hypertension, proteinuria, systemic endothelial cell activation and an exaggerated inflammatory response. The precise cause of preeclampsia is not currently known; however, it is widely accepted that the pathogenesis of preeclampsia involves inadequate trophoblast invasion, leading to generalized endothelial dysfunction and an exaggerated inflammatory response. Chemokines are a superfamily of structurally similar proteins that mediate cell recruitment, angiogenesis, immunity and stem cell trafficking. CXC chemokines are a family of cytokines, unique in their ability to behave in a disparate manner in the regulation of angiogenesis. The CXC chemokine family further divides into two subfamilies; CXC ELR+, which promotes angiogenesis, and CXC ELR-, which inhibits angiogenesis. Furthermore, CXC chemokines are involved in the pathogenesis of various conditions, including malignant tumors, wound repair, chronic inflammation, atherosclerosis and potentially preeclampsia.

Entities:  

Keywords:  CXC chemokines; angiogenesis; preeclampsia; trophoblast invasion

Year:  2015        PMID: 26136860      PMCID: PMC4471657          DOI: 10.3892/etm.2015.2337

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  60 in total

1.  The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes.

Authors:  Karl Balabanian; Bernard Lagane; Simona Infantino; Ken Y C Chow; Julie Harriague; Barbara Moepps; Fernando Arenzana-Seisdedos; Marcus Thelen; Françoise Bachelerie
Journal:  J Biol Chem       Date:  2005-08-17       Impact factor: 5.157

Review 2.  The molecular biology of leukocyte chemoattractant receptors.

Authors:  P M Murphy
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

3.  Epigenetic mechanisms of promigratory chemokine CXCL14 regulation in human prostate cancer cells.

Authors:  Eun Young Song; Michael R Shurin; Irina L Tourkova; Dmitriy W Gutkin; Galina V Shurin
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

4.  Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism.

Authors:  E Loukinova; G Dong; I Enamorado-Ayalya; G R Thomas; Z Chen; H Schreiber; C Van Waes
Journal:  Oncogene       Date:  2000-07-20       Impact factor: 9.867

5.  Improved survival in tumor-bearing SCID mice treated with interferon-gamma-inducible protein 10 (IP-10/CXCL10).

Authors:  D A Arenberg; E S White; M D Burdick; S R Strom; R M Strieter
Journal:  Cancer Immunol Immunother       Date:  2001-12       Impact factor: 6.968

6.  The two stage model of preeclampsia: variations on the theme.

Authors:  J M Roberts; C A Hubel
Journal:  Placenta       Date:  2008-12-13       Impact factor: 3.481

7.  Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion.

Authors:  David Zagzag; Yevgeniy Lukyanov; Li Lan; M Aktar Ali; Mine Esencay; Olga Mendez; Herman Yee; Evelyn B Voura; Elizabeth W Newcomb
Journal:  Lab Invest       Date:  2006-10-30       Impact factor: 5.662

Review 8.  Angiogenic factors and preeclampsia.

Authors:  Guy Steinberg; Eliyahu V Khankin; S Ananth Karumanchi
Journal:  Thromb Res       Date:  2009       Impact factor: 3.944

Review 9.  Cancer CXC chemokine networks and tumour angiogenesis.

Authors:  Robert M Strieter; Marie D Burdick; Javier Mestas; Brigitte Gomperts; Michael P Keane; John A Belperio
Journal:  Eur J Cancer       Date:  2006-02-28       Impact factor: 9.162

10.  An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.

Authors:  Laura Lasagni; Michela Francalanci; Francesco Annunziato; Elena Lazzeri; Stefano Giannini; Lorenzo Cosmi; Costanza Sagrinati; Benedetta Mazzinghi; Claudio Orlando; Enrico Maggi; Fabio Marra; Sergio Romagnani; Mario Serio; Paola Romagnani
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  8 in total

Review 1.  Candidate Gene, Genome-Wide Association and Bioinformatic Studies in Pre-eclampsia: a Review.

Authors:  Semone Thakoordeen; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2018-08-29       Impact factor: 5.369

2.  Immunological comparison of pregnant Dahl salt-sensitive and Sprague-Dawley rats commonly used to model characteristics of preeclampsia.

Authors:  Erin B Taylor; Eric M George; Michael J Ryan; Michael R Garrett; Jennifer M Sasser
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-06-09       Impact factor: 3.210

3.  High Levels of CXCL8 and Low Levels of CXCL9 and CXCL10 in Women with Maternal RhD Alloimmunization.

Authors:  Juliana Araújo de Carvalho Schettini; Thomás Virgílio Gomes; Alexandra Karla Santos Barreto; Claudeir Dias da Silva Júnior; Marina da Matta; Isabela Cristina Neiva Coutinho; Maria do Carmo Valgueiro Costa de Oliveira; Leuridan Cavalcante Torres
Journal:  Front Immunol       Date:  2017-07-03       Impact factor: 7.561

4.  Transthyretin regulates the migration and invasion of JEG-3 cells.

Authors:  Liyun Gong; Lei Zhu; Shuzhen Wang; Zhenyu Zhang
Journal:  Oncol Lett       Date:  2016-12-28       Impact factor: 2.967

5.  CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients.

Authors:  Yifan Cao; Hao Liu; Heng Zhang; Chao Lin; Ruochen Li; Songyang Wu; He Li; Hongyong He; Weijuan Zhang; Jiejie Xu
Journal:  Oncotarget       Date:  2017-03-21

6.  Proteomics and Metabolomics Profiling of Platelets and Plasma Mediators of Thrombo-Inflammation in Gestational Hypertension and Preeclampsia.

Authors:  Luiz Gustavo N de Almeida; Daniel Young; Lorraine Chow; Joshua Nicholas; Adrienne Lee; Man-Chiu Poon; Antoine Dufour; Ejaife O Agbani
Journal:  Cells       Date:  2022-04-07       Impact factor: 7.666

7.  CXCL14-like Immunoreactivity Exists in Somatostatin-containing Endocrine Cells, and in the Lamina Propria and Submucosal Somatostatinergic Nervous System of Mouse Alimentary Tract.

Authors:  Hirohumi Suzuki; Kentaro Yamada; Yasuhiro Matsuda; Minoru Onozuka; Toshiharu Yamamoto
Journal:  Acta Histochem Cytochem       Date:  2017-11-23       Impact factor: 1.938

8.  Bioinformatics-based identification of miRNA-, lncRNA-, and mRNA-associated ceRNA networks and potential biomarkers for preeclampsia.

Authors:  Ruoan Jiang; Ting Wang; Feifei Zhou; Yingsha Yao; Jing He; Dong Xu
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.